(S (S (VP (VBG Demonstrating) (NP (NP (DT the) (JJ practical) (NN value)) (PP (IN of) (NP (JJ public) (NN research)))))) (VP (VBZ has) (VP (VBN been) (NP (DT an) (JJ important) (NN subject)) (PP (IN in) (NP (NN science) (NN policy))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ detailed) (NN study)) (PP (IN on) (NP (NP (DT the) (NN evolution)) (PP (IN of) (NP (NP (DT the) (NN citation) (NN linkage)) (PP (IN between) (NP (NP (NN life) (NN science) (VBN related) (NNS patents)) (CC and) (NP (JJ biomedical) (NN research)))))) (PP (IN over) (NP (DT a) (JJ 37-year) (NN period))))))) (. .))
(S (NP (PRP$ Our) (NN analysis)) (VP (NNS relies) (PP (IN on) (NP (NP (DT a) (JJ newly-created) (NN dataset)) (SBAR (WHNP (WDT that)) (S (VP (ADVP (RB systematically)) (VBZ links) (NP (NP (NNS millions)) (PP (IN of) (NP (NP (JJ non-patent) (NNS references)) (PP (TO to) (NP (JJ biomedical) (NNS papers)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP find) (NP (NP (DT a) (JJ large) (NN disparity)) (PP (IN in) (NP (NP (DT the) (NN volume)) (PP (IN of) (NP (NN science) (NN linkage))) (PP (IN among) (NP (NN technology) (NNS sectors)))))) (, ,) (PP (IN with) (S (NP (NP (NN biotechnology)) (CC and) (NP (NN drug) (NNS patents))) (VP (VBG dominating) (NP (PRP it)))))) (. .))
(S (NP (DT The) (NN linkage)) (VP (VBZ has) (VP (VBN been) (VP (VBG growing) (ADVP (RB exponentially)) (PP (IN over) (NP (NP (DT a) (JJ long) (NN period)) (PP (IN of) (NP (NN time))))) (, ,) (S (VP (VBG doubling) (NP (DT every) (CD 2.9) (NNS years))))))) (. .))
(S (NP (DT The) (NNP U.S.)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT the) (JJS largest) (NN producer)) (PP (IN of) (NP (JJ cited) (NN science)))) (PP (IN for) (NP (NNS years))) (, ,) (S (VP (VBG receiving) (NP (NP (QP (RB nearly) (NN half))) (PP (IN of) (NP (DT the) (NNS citations)))))))) (. .))
(S (NP (NP (QP (JJR More) (IN than) (NN half))) (PP (IN of) (NP (NNS citations)))) (VP (VBZ goes) (PP (TO to) (NP (NNS universities)))) (. .))
(S (NP (PRP We)) (VP (VBP use) (NP (DT a) (JJ new) (JJ paper-level) (NN indicator)) (S (VP (TO to) (VP (VB quantify) (SBAR (WHPP (TO to) (WHNP (WP what) (VB extent))) (S (NP (DT a) (NN paper)) (VP (VBZ is) (NP (NP (JJ basic) (NN research)) (CC or) (NP (JJ clinical) (NN medicine)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP find) (SBAR (IN that) (S (S (NP (DT the) (JJ cited) (NNS papers)) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (NP (JJ basic) (NN research)))))))) (, ,) (CC yet) (S (NP (NP (DT a) (JJ significant) (NN portion)) (PP (IN of) (NP (NP (NNS papers)) (VP (VBN cited) (PP (IN in) (NP (NNS patents)))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN related) (PP (TO to) (NP (NNP FDA-approved) (NNS drugs)))))))))) (VP (VBP are) (NP (JJ clinical) (NN research))))))) (. .))
(S (NP (NP (DT The) (NNP U.S.) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Health)))) (VP (VBZ continues) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ important) (NN funder)) (PP (IN of) (NP (JJ cited) (NN science)))))))) (. .))
(S (PP (IN For) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (NNS companies))))) (, ,) (NP (NP (QP (JJR more) (IN than) (NN half))) (PP (IN of) (NP (NP (NNS citations)) (PP (IN in) (NP (PRP$ their) (NNS patents)))))) (VP (VBP are) (VP (VBN authored) (PP (IN by) (NP (JJ public) (NN research))))) (. .))
(S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS results)) (VP (VBP indicate) (NP (NP (DT a) (JJ continuous) (NN linkage)) (PP (IN of) (NP (JJ public) (NN science))) (PP (TO to) (NP (JJ private) (NN sector) (NNS inventions))))) (. .))
